BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35440308)

  • 1. Alzheimer's Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment.
    Benmelouka AY; Ouerdane Y; Outani O; Alnasser YT; Alghamdi BS; Perveen A; Ashraf GM; Ebada MA
    Curr Alzheimer Res; 2022; 19(4):285-301. PubMed ID: 35440308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
    Christie D; Shofer J; Millard SP; Li E; Demichele-Sweet MA; Weamer EA; Kamboh MI; Lopez OL; Sweet RA; Tsuang D
    Behav Brain Funct; 2012 Dec; 8():62. PubMed ID: 23270420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of psychosis in dementia: a comparison of assessment tools.
    Cohen-Mansfield J; Golander H
    Alzheimer Dis Assoc Disord; 2011; 25(2):101-8. PubMed ID: 20921878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of late-onset psychoses.
    Devanand DP; Jeste DV; Stroup TS; Goldberg TE
    Int Psychogeriatr; 2024 Jan; 36(1):28-42. PubMed ID: 36866576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis.
    Sabbagh M; Small GW; Isaacson SH; Torres-Yaghi Y; Pagan F; Pahwa R
    Int J Psychiatry Clin Pract; 2023 Mar; 27(1):69-81. PubMed ID: 35574992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.
    Naasan G; Shdo SM; Rodriguez EM; Spina S; Grinberg L; Lopez L; Karydas A; Seeley WW; Miller BL; Rankin KP
    Brain; 2021 Apr; 144(3):999-1012. PubMed ID: 33501939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.
    El Haj M; Roche J; Jardri R; Kapogiannis D; Gallouj K; Antoine P
    Neurosci Biobehav Rev; 2017 Dec; 83():713-720. PubMed ID: 28235545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis of Alzheimer's disease: clinical characteristics and history.
    Schneider LS; Dagerman KS
    J Psychiatr Res; 2004 Jan; 38(1):105-11. PubMed ID: 14690773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis and dementia: risk factor, prodrome, or cause?
    Fischer CE; Agüera-Ortiz L
    Int Psychogeriatr; 2018 Feb; 30(2):209-219. PubMed ID: 28560931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with psychotic symptoms in Alzheimer's disease.
    Hirono N; Mori E; Yasuda M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Hashimoto M; Yamashita H
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):648-52. PubMed ID: 9598682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis and physical aggression in probable Alzheimer's disease.
    Deutsch LH; Bylsma FW; Rovner BW; Steele C; Folstein MF
    Am J Psychiatry; 1991 Sep; 148(9):1159-63. PubMed ID: 1882992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.
    Gormley N; Rizwan MR
    Int J Geriatr Psychiatry; 1998 Jun; 13(6):410-4. PubMed ID: 9658277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variables associated with psychosis in Alzheimer's disease.
    Kotrla KJ; Chacko RC; Harper RG; Doody R
    Am J Psychiatry; 1995 Sep; 152(9):1377-9. PubMed ID: 7653698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
    J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.
    Ropacki SA; Jeste DV
    Am J Psychiatry; 2005 Nov; 162(11):2022-30. PubMed ID: 16263838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT findings on psychosis in Alzheimer's disease.
    Kotrla KJ; Chacko RC; Harper RG; Jhingran S; Doody R
    Am J Psychiatry; 1995 Oct; 152(10):1470-5. PubMed ID: 7573586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(9):818-28. PubMed ID: 25323000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Connors MH; Ames D; Woodward M; Brodaty H
    Am J Geriatr Psychiatry; 2018 Mar; 26(3):304-313. PubMed ID: 29174998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.